Skip to main content
Premium Trial:

Request an Annual Quote

Alternative Computing

A number of startups are looking into alternative computing approaches, including DNA computing, to handle rising processing and storage demands, the Wall Street Journal reports.

A Boston-based startup called Catalog Technologies is pursuing DNA-based data storage, and according to the Journal, it relies on molecular biology tools to print synthetic molecules in which to store information and that the data can then be read by sequencing the sample and running it through a proprietary software program to return it to its original text, photo, or video form. The Journal adds that the firm recently showed it could store 14 gigabytes of data from Wikipedia within DNA molecules in a test tube.

Other companies, meanwhile, are exploring quantum computing and other approaches.

But these new approaches are "fraught with risk" for investors, Adam Fisher, a partner at Bessemer Venture Partners, tells the Journal. He notes that that's because they need new architectures. But still, his firm is looking to invest in quantum computing, it adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.